Search Results 481-490 of 17676 for Prednisone

  1. Phendimetrazine (oral route) - Side effects & dosage - Mayo Clinic

    Phendimetrazine is used for weight reduction in patients with obesity who have not been able to lose weight with diet and exercise alone. This medicine works by ...

  2. centers-of-excellence

    Science Saturday: Mayo researchers streamline genetic testing in heart failure clinic, improve clinical care - Mayo Clinic News Network Skip to Navigation --> ...

  3. A Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) - Mayo Clinic

    The patient has been taking prednisone at a dose > 10 mg/day (or equivalent dose of an alternative glucocorticoid) within 4 weeks prior to Visit 1 (Screening ...

  4. Ciclesonide (inhalation route) - Side effects & dosage - Mayo Clinic

    Ciclesonide is a corticosteroid or steroid (cortisone-like medicine). It works by preventing inflammation (swelling) in the lungs, which makes the asthma attack ...

  5. Ospemifene (oral route) - Side effects & dosage - Mayo Clinic

    Prednisone; Primidone; Rifabutin; Rifampin; Rifapentine; Secobarbital; St John's Wort; Thiopental. Other Interactions. Certain medicines should not be used at ...

  6. Hydrocodone and ibuprofen (oral route) - Side effects & dosage - Mayo Clinic

    Hydrocodone is an opioid analgesic that acts on the central nervous system to relieve pain. If hydrocodone is used for a long time, it may become habit-forming ...

  7. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    Patients should be neurologically stable and requiring ≤ 10mg oral prednisone equivalence of steroids per day. Any toxicity from immune-related toxicity ...

  8. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

    ... prednisone or equivalent permitted - Adrenal replacement steroid doses including doses >10 mg daily prednisone is permitted - A brief (less than 3 weeks) ...

  9. A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    ... prednisone, enzalutamide) for metastatic castration-resistant prostate cancer (mCRPC). Participants must have had at least 4 weeks of AR-targeted therapy ...

  10. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... prednisone, and Cohort C will receive pembrolizumab + enzalutamide. Outcome measures will be assessed individually for each cohort. Participation ...